In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

LiverTrace is designed for adults considered at risk for liver cancer, including those with previous liver conditions.

Deep learning model analyzes mammograms to predict breast cancer risk up to five years in advance, now being tested at ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

A new AI tool BMVision speeds up kidney cancer detection, cutting radiology review time by a third and supporting earlier, ...

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

OHSU radiation oncologist presents promising study findings, launches a third, Medicare-backed study Nima Nabavizadeh, M.D., ...

For the last three years, the world has obsessed over generative AI that can write and create. By the end of 2026, we'll see ...